|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Oct 01, 2018 |
Title |
SH_TS_BC59 |
Sample type |
SRA |
|
|
Source name |
Breast cancer
|
Organism |
Homo sapiens |
Characteristics |
gender: female dmfs time: NA dmfs event: NA sample type: Solid tumor irdm subtype: LumA pam50 subtype: LumA immunity group: iweak proliferation group: low er status rna: ER+ pr status rna: PR+
|
Extracted molecule |
total RNA |
Extraction protocol |
FFPE tissues total RNA extraction was routinely performed using Roche FFPE RNA extraction kit according to the manufacturer’s protocol. The Illumina TruSeq Targeted RNA expression kit was used to build libraries of the targeted 72-genes. To synthesize cDNA, 200 to 800 nanograms of purified FFPE RNA in a total volume of 3 µl was mixed with 4.0 µl RCS1, 2.0 µl ProtoScrip II Reverse Transcriptase, 1.0 µl 10mM DTT at 42OC for 30 min and 94OC for 10 min. The cDNA was hybridized with custom oligo pools in a thermal cycler programed to gradually decrease temperature from 70 OC to 30 OC in 30 minutes. The RNA/Oligo hybrid products were washed, extended and ligated. The ligated DNA was amplified by DNA polymerase on the thermal cycler with 35 PCR cycles of 98 OC for 30 seconds, 62 OC for 30 seconds and 72 OC for 60 seconds. The PCR products were purified with AMPure XP beads and eluted in 15 µl of buffer, measured using Agilent Bioanalyzer2100 and DNA1000 chips, pooled with equal amounts of DNA from each sample’s library, and finally diluted to 4 nM, denatured, and loaded to Nextseq500 according to the manufacturer’s protocol. Libraries were multiplexed and sequenced on Illumina Nextseq500 to generate 75bp single read R1.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
FFPE RNA Targeted RNA-seq SH_TS_BC59
|
Data processing |
Illumina Casava1.7 software used for basecalling and sequencing data were demultiplexed based on dual indexes. Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence, demultiplexed and then only read 1 in each sample were mapped to known Targeted regions of human genomes for counts using R package "ShortRead". Raw counts of all samples were imported to edgeR for normalization by the size of the transcripts and by the size of the library and then calculation of CPM per sample as a gene expression matrix Gene expression CPM dataset were median-centered and column-standardized using DWD DWD dataset were used for iRDM data analysis including subtype classification, iRDM risks, immunity scores, and proliferation scores. Genome_build: hg19 Supplementary_files_format_and_content: csv files were generated including raw counts and normalized gene expression data
|
|
|
Submission date |
Apr 30, 2018 |
Last update date |
Oct 01, 2018 |
Contact name |
Zhiyuan Hu |
E-mail(s) |
HUZI1111@OUTLOOK.COM
|
Phone |
9195274295
|
Organization name |
University of North Carolina at Chapel Hill
|
Department |
Lineberger Comprehensive Cancer Center
|
Lab |
RAM lab
|
Street address |
450 West Dr
|
City |
Chapel Hill |
State/province |
NC |
ZIP/Postal code |
27502 |
Country |
USA |
|
|
Platform ID |
GPL18573 |
Series (1) |
GSE113863 |
An assessment of prognostic immunity markers in breast cancer |
|
Relations |
BioSample |
SAMN09001733 |
SRA |
SRX4013357 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|